Mirati Therapeutics, Inc.

WELLINGTON MANAGEMENT GROUP LLP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

3,319,922

Value ($000)

144,616

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	144,616	0.0%	3,319,922	9/30/2023
2023 Q2	8/14/2023	122,422	0.0%	3,388,365	6/30/2023
2023 Q1	5/12/2023	100,241	0.0%	2,696,092	3/31/2023
2022 Q4	2/13/2023	136,670	0.0%	3,016,335	12/31/2022
2022 Q3	11/14/2022	242,297	0.1%	3,469,311	9/30/2022
2022 Q2	8/15/2022	195,082	0.0%	2,906,030	6/30/2022
2022 Q1	5/16/2022	204,113	0.0%	2,482,521	3/31/2022
2021 Q4	2/11/2022	461,606	0.1%	3,146,815	12/31/2021
2021 Q3	11/15/2021	608,611	0.1%	3,440,222	9/30/2021
2021 Q2	8/16/2021	501,306	0.1%	3,103,485	6/30/2021
2021 Q1	5/17/2021	374,534	0.1%	2,186,418	3/31/2021
2020 Q4	2/12/2021	495,262	0.1%	2,254,882	12/31/2020
2020 Q3	11/16/2020	271,893	0.1%	1,637,420	9/30/2020
2020 Q2	8/14/2020	206,042	0.0%	1,804,701	6/30/2020
2020 Q1	5/14/2020	133,443	0.0%	1,735,957	3/31/2020
2019 Q4	2/11/2020	76,694	0.0%	595,180	12/31/2019